We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
ChinaBio® Partnering Forum Digital is an online platform for scheduled virtual partnering meetings, recorded content, some live sessions and virtual networking opportunities during the week of August 25–27.
Company pitches and program sessions, as well as enhanced Sponsor and Company Showcase content will be available to complement partnering preparations.
OCT Clinical will be represented by Polina Nabieva, a business development manager pnabieva@oct-clinicaltrials.com
Book a meeting with our team to discuss your clinical trial options in Europe.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.